Contract notice
Section I: Contracting
authority
I.1) Name and addresses
King's College London
James Clerk Maxwell Building, 57 Waterloo Road
London
SE1 8WA
UK
Contact person: Darran Whatley
E-mail: darran.whatley@kcl.ac.uk
NUTS: UK
Internet address(es)
Main address: www.kcl.ac.uk
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
http://www.kcl.ac.uk/aboutkings/orgstructure/ps/purchasing/suppliers/etender.aspx
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
http://www.kcl.ac.uk/aboutkings/orgstructure/ps/purchasing/suppliers/etender.aspx
Tenders or requests to participate must be sent to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
http://www.kcl.ac.uk/aboutkings/orgstructure/ps/purchasing/suppliers/etender.aspx
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Education
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Randomized, Placebo Controlled Phase 2 Study of Immunotherapy in New-onset Type 1 Diabetes
Reference number: KCL-00001262
II.1.2) Main CPV code
73110000
II.1.3) Type of contract
Services
II.1.4) Short description
The context and aims of the overall research programme and the clinical trial in particular, are described in section 1 – part A. Here, we set out the assumptions we have made for the trial design and conduct, and invite tenderers to respond, suggesting variations where they believe this will help achieve our aims, or will deliver a higher quality or more cost effective survey.
II.1.5) Estimated total value
Value excluding VAT:
9 000 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
II.2.4) Description of the procurement
The context and aims of the overall research programme, and the clinical trial in particular, are described in section 1 – part A. Here, we set out the assumptions we have made for the trial design and conduct, and invite tenderers to respond, suggesting variations where they believe this will help achieve our aims, or will deliver a higher quality or more cost effective survey.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
14/08/2020
End:
31/12/2024
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
Yes
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:
List and brief description of conditions: As per the tender documents.
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
20/07/2020
Local time: 10:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.7) Conditions for opening of tenders
Date:
27/07/2020
Local time: 11:00
Place:
Online by Procurement Strategy and Services team at King's College London.
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4) Procedures for review
VI.4.1) Review body
Royal Courts of Justice
Strand
London
WC2A 2LL
UK
E-mail: comct.registry@hmcourts-service.gsi.gov.uk
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
VI.5) Date of dispatch of this notice
26/06/2020